Medtronic (MDT) Common Equity (2013 - 2026)

Medtronic has disclosed Common Equity across 14 years of filings, most recently posting $49.0 billion for Q1 2026.

• Common Equity for Q1 2026 came in at $49.0 billion, down 1.27% year-over-year; the trailing twelve-month figure through Jan 2026 was $49.0 billion (down 1.27% YoY), and the FY2025 annual result was $48.0 billion, down 4.75% from the prior year.
• Common Equity came in at $49.0 billion for Q1 2026 at Medtronic, roughly flat from $48.9 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $52.8 billion in Q3 2022 to a low of $48.0 billion in Q2 2025.
• The 5-year median for Common Equity is $51.4 billion (2023), against an average of $50.6 billion.
• Across the five-year window, Common Equity rose 3.5% in 2022 and dropped 6.24% in 2024, its largest moves.
• Medtronic's Common Equity stood at $52.1 billion in 2022, then fell by 0.79% to $51.6 billion in 2023, then declined by 5.68% to $48.7 billion in 2024, then increased by 0.29% to $48.9 billion in 2025, then rose by 0.26% to $49.0 billion in 2026.
• The last three Common Equity figures came in at $49.0 billion (Q1 2026), $48.9 billion (Q4 2025), and $48.1 billion (Q3 2025), per Business Quant data.